The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years

NCT00147615 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Eplerenone

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.